Cefixime/Ofloxacin

头孢克肟/氧氟沙星

Report date: 2026/04/21 20:00:18

Base Information

Drug NameCefixime/Ofloxacin

Drug Alias Name氧氟沙星/头孢克肟Ofloxacin/CefiximeCefixime and OfloxacinOfloxacin and CefiximeCefidex

ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Quinolone antibioticsSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Cephalosporins antibiotics > Third-generation cephalosporins

Mechanisms of ActionBacterial DNA gyrase inhibitorsCell wall inhibitorsBacterial penicillin-binding protein inhibitors +[4]

TargetsTopoisomerase IVBacterial DNA gyraseBacterial penicillin-binding protein

Therapy Area/IndicationsTyphoid Fever

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsYes Ofloxacin Cefixime

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaN/A

Originator CompaniesAssociated Biotech

China Registration ClassN/A

Develop Information

Active CompaniesAssociated Biotech

Inactive CompaniesN/A

Active IndicationsTyphoid Fever

Inactive IndicationsN/A

Other Information

ATC CodeN/A